Table 2. Univariate and multivariate analyses of OS in 195 cases of oral cancer.
Univariate analysis | Multivariate analysis | |||||||
---|---|---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |||
Variable | Low | High | Low | High | ||||
Age (> 50 vs. ≦ 50 years) | 1.216 | 0.781 | 1.892 | 0.387 | ||||
Sex (Male vs. Female) | 2.295 | 0.565 | 9.325 | 0.246 | ||||
Stage (III/IV vs. I/II) | 3.013 | 1.953 | 4.646 | < 0.001* | 2.019 | 1.156 | 3.525 | 0.013* |
Grade (G3 vs. G1/G2) | 1.328 | 0.737 | 2.393 | 0.344 | ||||
Lymphovascular invasion (Present vs. Absent) | 3.399 | 2.211 | 5.225 | < 0.001* | 2.406 | 1.416 | 4.088 | 0.001* |
Necrosis (Extensive vs. Limited/no) | 1.828 | 1.182 | 2.825 | 0.007* | 1.272 | 0.798 | 2.028 | 0.313 |
Cytoplasmic Beclin 1 (High vs. Low) | 1.443 | 0.953 | 2.186 | 0.083 | ||||
Nuclear Beclin 1 (Positive vs. Negative) | 1.278 | 0.734 | 2.228 | 0.386 | ||||
Cytoplasmic Beclin 2 | ||||||||
Low vs. Moderate | 2.253 | 1.369 | 3.709 | 0.001* | 2.698 | 1.614 | 4.509 | < 0.001* |
High vs. Moderate | 1.975 | 1.152 | 3.388 | 0.013* | 1.865 | 1.084 | 3.207 | 0.024* |
Nuclear Beclin 2 (Positive vs. Negative) | 1.130 | 0.639 | 2.001 | 0.674 |
OS, overall survival; CI, confidence interval.
* P< 0.05